ロード中...
Neuropharmacological Actions of Metformin in Stroke
Increasing epidemiologic evidence suggests that metformin, a well-established AMPK activator and the most favorable first-line anti-diabetic drug, reduces stroke incidence and severity. However, the mechanism for this remains unclear. Moreover, previous experimental studies have reported controversi...
保存先:
| 出版年: | Curr Neuropharmacol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Bentham Science Publishers
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812800/ https://ncbi.nlm.nih.gov/pubmed/26411966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150205143555 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|